New Research on Anxiety Disorders in the Elderly and an Update on Evidence-Based Treatments

被引:53
|
作者
Andreescu, Carmen [1 ]
Varon, Daniel [1 ]
机构
[1] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Sch Med, Pittsburgh, PA 15213 USA
关键词
Anxiety disorders; Elderly; Neurobiological research; Evidence-based treatment; MILD COGNITIVE IMPAIRMENT; SEROTONIN REUPTAKE INHIBITORS; OLDER-ADULTS; DOUBLE-BLIND; NEUROPSYCHIATRIC SYMPTOMS; FUNCTIONAL CONNECTIVITY; BEHAVIORAL-THERAPY; AMYLOID-BETA; BENZODIAZEPINE USE; SALIVARY CORTISOL;
D O I
10.1007/s11920-015-0595-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Anxiety disorders are frequently encountered in the elderly, but they are largely undetected and untreated. Epidemiological studies indicate a prevalence ranging from 1.2 to 15 %. With the exception of generalized anxiety disorder and agoraphobia, which can often start in late life, most anxiety disorders in older patients are chronic and have their onset earlier in life. Anxiety disorders are an often unrecognized cause of distress, disability, and mortality risk in older adults, and they have been associated with cardiovascular disease, stroke, and cognitive decline. The mechanisms of anxiety in older adults differ from that in younger adults due to age-related neuropathology, as well as the loss and isolation so prominent in late life. Our review intends to provide a comprehensive summary of the most recent research done in the field of anxiety disorders in the elderly. Recent findings in clinical research, neuroimaging, neuroendocrinology, and neuropsychology are covered. An update on treatment options is discussed, including pharmacological and non-pharmacological alternatives.
引用
收藏
页数:7
相关论文
共 50 条